Preoperative fibrin monomer measurement allows risk stratification for high intraoperative blood loss in elective surgery

Summary

We recently demonstrated that patients with increased blood loss due to intraoperative coagulopathy show a persistent pre-, intra- and postoperative increase in fibrin monomer concentration. We thus tested the hypothesis that preoperative fibrin monomer concentrations can be used as a risk indicator for intraoperative blood loss in a study designed for diagnostic test evaluation in 168 patients admitted to the surgical service of our hospital. Intraoperative blood loss increased with preoperative fibrin monomer concentration (median blood loss of 50, 100, 200 and 400 ml in preoperative fibrin monomer quartile groups 1 to 4, p<0.001,ANOVA on ranks; interquartile comparisons p < 0.05 (4/6), MannWhitney Rank Sum test). In contrast, intraoperative blood loss was unrelated to preoperative values of prothrombin time, activated partial thromboplastin time and platelet count. By multivariate (logistic regression) analysis, only fibrin monomer remained a significant predictor of intraoperative blood loss > 500 ml when age, gender, BMI, fibrin monomer and the different types of surgical procedures (tumor surgery, vascular surgery, cholecystectomy, gastric banding, varicous vein surgery and hernia repair) were included as independent variables. Most importantly, accuracy evaluation showed that preoperative fibrin monomer concentration < 3 μg/l excluded intraoperative blood loss > 500 ml with 92% sensitivity and 95% negative predictive value. These results support our hypothesis that preoperative fibrin monomer concentrations are related to intraoperative blood loss in elective surgery. Fibrin monomer should be further investigated for it’s potential to serve as a routine tool for preoperative risk stratification of intraoperative bleeding.

Keywords

Acquired coagulation disorders - clinical/epidemiological studies - fibrinogen/fibrin

• References

• 1 McGinn FP. Effects of haemorrhage upon surgical operations. Br J Surg 1976; 63: 742-6.
• 2 Mor E, Jennings L, Gonwa TA. et al. The impact of operative bleeding on outcome in transplantation of the liver. Surg Gynecol Obstet 1993; 176: 219-27.
• 3 Tanabe G, Sakamoto M, Akazawa K. et al. Intraoperative risk factors associated with hepatic resection. Br J Surg 1995; 82: 1262-5.
• 4 Palomo Sanchez JC, Jimenez C, Moreno Gonzalez E. et al. Effects of intraoperative blood transfusion on postoperative complications and survival after orthotopic liver transplantation. Hepatogastroenterology 1998; 45: 1026-33.
• 5 Burk CD, Miller L, Handler SD. et al. Preoperative history and coagulation screening in children undergoing tonsillectomy. Pediatrics 1992; 89: 691-5.
• 6 Kozak EA, Brath LK. Do ‘‘screening” coagulation tests predict bleeding in patients undergoing fiberoptic bronchoscopy with biopsy?. Chest 1994; 106: 703-5.
• 7 Nuttall GA, Oliver WC, Ereth MH. et al. Coagulation tests predict bleeding after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1997; 11: 815-23.
• 8 Schramm B, Leslie K, Myles PS. et al. Coagulation studies in preoperative neurosurgical patients. Anaesth Intensive Care 2001; 29: 388-92.
• 9 Sutterlin R, Barthels D. [Recommendations for initial diagnosis and therapy in acute blood coagulation disorders]. Anaesthesiol Reanim 1996; 21: 76-80.
• 10 Myers ER, Clarke-Pearson DL, Olt GJ. et al. Preoperative coagulation testing on a gynecologic oncology service. Obst Gynecol 1994; 83: 438-44.
• 11 Livingston ER, Fisher CA, Bibidakis EJ. et al. Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation. Circulation 1996; 94: II227-34.
• 12 Korte W, Truttmann B, Heim C. et al. Preoperative values of molecular coagulation markers identify patients at low risk for intraoperative haemostatic disorders and excessive blood loss. Clin Chem Lab Med 1998; 36: 235-40.
• 13 Brown JV, Karlan BY, Greenspoon JS. et al. Perioperative coagulopathy in patients undergoing primary cytoreduction. Cancer 1993; 71: 2557-61.
• 14 Mayer PJ, Gehlsen JA. Coagulopathies associated with major spinal surgery. Clin Orthop 1989; 245: 83-8.
• 15 Wettstein P, Haeberli A, Stutz M. et al. Decreased Factor XIII availability for thrombin and early loss of clot firmness in patients with unexplained intraoperative bleeding. Anesth Analg 2004; 99: 1564-9.
• 16 Ransohoff DF, Feinstein AR. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med 1978; 299: 926-30.
• 17 Mulherin SA, Miller WC. Spectrum bias or spectrum effect? Subgroup variation in diagnostic test evaluation. Ann Intern Med 2002; 137: 598-602.
• 18 FAEM. http://www.faem.org.uk/site/research/technical_guide/techpages/diagnostic.htm
• 19 Valle I, Sola G, Origone A. Controlled clinical study of the efficacy of a new low molecular weight heparin administered subcutaneously to prevent post-operative deep venous thrombosis. Curr Med Res Opin 1988; 11: 80-6.
• 20 Leclerc JR, Geerts WH, Desjardins L. et al. Prevention of deep vein thrombosis after major knee surgery– a randomized, double-blind trial comparing a low molecular weight heparin fragment (enoxaparin) to placebo. Thromb Haemost 1992; 67: 417-23.
• 21 Gondret R, Dominici L, Angelard B. et al. Safety of preoperative enoxaparin in head and neck cancer surgery. Head Neck 1995; 17: 1-6.
• 22 Woodburn KR, Lowe GD. Fibrinogen, fibrin turnover, endothelial products and vascular surgery. Br J Surg 1997; 84: 1059-64.
• 23 Boyle Jr. EM, Verrier ED, Spiess BD. Endothelial cell injury in cardiovascular surgery: the procoagulant response. Ann Thorac Surg 1996; 62: 1549-57.
• 24 Schafer M, Krahenbuhl L, Buchler MW. Predictive factors for the type of surgery in acute cholecystitis. Am J Surg 2001; 182: 291-7.
• 25 Stuttmann R, Paul A, Kirschnik M. et al. Preoperative morbidity and anaesthesia-related negative events in patients undergoing conventional or laparoscopic cholecystectomy. Endosc Surg Allied Technol 1995; 3: 156-61.
• 26 Freyburger G, Trillaud H, Labrouche S. et al. D-dimer strategy in thrombosis exclusion–a gold standard study in 100 patients suspected of deep venous thrombosis or pulmonary embolism: 8 DD methods compared. Thromb Haemost 1998; 79: 32-7.
• 27 Funfsinn N, Caliezi C, Biasiutti FD. et al. Rapid D-dimer testing and pre-test clinical probability in the exclusion of deep venous thrombosis in symptomatic outpatients. Blood Coagul Fibrinolysis 2001; 12: 165-70.
• 28 Royston D, von Kier S. Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass. Br J Anaesth 2001; 86: 575-8.
• 29 Aucar JA, Norman P, Whitten E. et al. Intraoperative detection of traumatic coagulopathy using the activated coagulation time. Shock 2003; 19: 404-7.
• 30 Shih RL, Cherng YG, Chao A. et al. Prediction of bleeding diathesis in patients undergoing cardiopulmonary bypass during cardiac surgery: viscoelastic measures versus routine coagulation test. Acta Anaesthesiol Sin 1997; 35: 133-9.